BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 8962455)

  • 41. A group-sequential design for clinical trials with treatment selection.
    Stallard N; Friede T
    Stat Med; 2008 Dec; 27(29):6209-27. PubMed ID: 18792085
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A generalized log-rank test for interval-censored failure time data via multiple imputation.
    Huang J; Lee C; Yu Q
    Stat Med; 2008 Jul; 27(17):3217-26. PubMed ID: 18254128
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Tests for homogeneity of the risk difference when data are sparse.
    Lipsitz SR; Dear KB; Laird NM; Molenberghs G
    Biometrics; 1998 Mar; 54(1):148-60. PubMed ID: 9544513
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Tests for multivariate recurrent events in the presence of a terminal event.
    Chen BE; Cook RJ
    Biostatistics; 2004 Jan; 5(1):129-43. PubMed ID: 14744832
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Bayesian predictive power for interim adaptation in seamless phase II/III trials where the endpoint is survival up to some specified timepoint.
    Schmidli H; Bretz F; Racine-Poon A
    Stat Med; 2007 Nov; 26(27):4925-38. PubMed ID: 17590875
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Refractory acute kidney transplant rejection with CD20 graft infiltrates and successful therapy with rituximab.
    Alausa M; Almagro U; Siddiqi N; Zuiderweg R; Medipalli R; Hariharan S
    Clin Transplant; 2005 Feb; 19(1):137-40. PubMed ID: 15659147
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Nonparametric estimation for cumulative duration of adverse events.
    Wang J; Quartey G
    Biom J; 2012 Jan; 54(1):61-74. PubMed ID: 22170311
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Simulation study comparing exposure matching with regression adjustment in an observational safety setting with group sequential monitoring.
    Stratton KG; Cook AJ; Jackson LA; Nelson JC
    Stat Med; 2015 Mar; 34(7):1117-33. PubMed ID: 25510526
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Robust non-parametric one-sample tests for the analysis of recurrent events.
    Rebora P; Galimberti S; Valsecchi MG
    Stat Med; 2010 Dec; 29(30):3137-46. PubMed ID: 21170908
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Variable selection for recurrent event data via nonconcave penalized estimating function.
    Tong X; Zhu L; Sun J
    Lifetime Data Anal; 2009 Jun; 15(2):197-215. PubMed ID: 19034646
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Nonparametric group sequential methods for recurrent and terminal events from multiple follow-up windows.
    Xia M; Murray S; Tayob N
    Stat Med; 2019 Dec; 38(30):5657-5669. PubMed ID: 31732980
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Marginal analysis of recurrent events and a terminating event.
    Cook RJ; Lawless JF
    Stat Med; 1997 Apr; 16(8):911-24. PubMed ID: 9160488
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Nonparametric and semiparametric trend analysis for stratified recurrence times.
    Wang MC; Chen YQ
    Biometrics; 2000 Sep; 56(3):789-94. PubMed ID: 10985217
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Robust covariate-adjusted log-rank statistics and corresponding sample size formula for recurrent events data.
    Song R; Kosorok MR; Cai J
    Biometrics; 2008 Sep; 64(3):741-750. PubMed ID: 18162107
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A gatekeeping procedure to test a primary and a secondary endpoint in a group sequential design with multiple interim looks.
    Tamhane AC; Gou J; Jennison C; Mehta CR; Curto T
    Biometrics; 2018 Mar; 74(1):40-48. PubMed ID: 28589692
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Regression analysis of multivariate recurrent event data with a dependent terminal event.
    Zhu L; Sun J; Tong X; Srivastava DK
    Lifetime Data Anal; 2010 Oct; 16(4):478-90. PubMed ID: 20217474
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Group sequential designs using a family of type I error probability spending functions.
    Hwang IK; Shih WJ; De Cani JS
    Stat Med; 1990 Dec; 9(12):1439-45. PubMed ID: 2281231
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Assessing differential drug effect.
    Berry DA; Eaton ML; Ekholm BP; Fox TL
    Biometrics; 1984 Dec; 40(4):1109-15. PubMed ID: 6398711
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Safety data from randomized controlled trials: applying models for recurrent events.
    Hengelbrock J; Gillhaus J; Kloss S; Leverkus F
    Pharm Stat; 2016 Jul; 15(4):315-23. PubMed ID: 27291933
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Adjusted regression trend test for a multicenter clinical trial.
    Quan H; Capizzi T
    Biometrics; 1999 Jun; 55(2):460-2. PubMed ID: 11318200
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.